Xiao Zang
Biographic Data
| ID | 6061293 |
|---|---|
| NAME | Xiao Zang |
| GIVEN NAMES | Xiao |
| FAMILY NAME | Zang |
| SIGNATURE | ZANG X |
| AFFILIATIONS | Brown University |
| ORCID | 0000-0002-5722-8255 |
| VERIFIED | Yes |
| TOTAL WORKS | 9 |
| TOTAL CITATIONS | 1 |
| WORKS AS AUTHOR | 9 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 1 |
A descriptive study of drug overdose epidemics, overdose prevention efforts, and opioid settlement fund distribution across six states
Enumeration 2024
Objectives. To expand on previous enumerations by assessing the size and composition of the governmental public health workforce in the wake of the COVID-19 pandemic, identifying workforce trends, occupational distributions, and potential gaps in staffing. Methods. From 2023 to 2024, using 2022 data in the United States, we conducted 3 distinct analyses: (1) estimating the total workforce size, (2) profiling occupation-specific distributions, and…
Enumerating the State and Local Public Health Workforce During the Covid-19 Response
Objectives. To understand the landscape of the nonfederal governmental public health workforce and to identify replicable methods for future enumerations. Methods. This enumeration of the state and local public health workforce was conducted from 2023 to 2024 and triangulated the National Association of County and City Health Officials (NACCHO) Profile 2022 and the Association of State and Territorial Health Officials (ASTHO) Profile 2022. We uti…
Population-level health and economic impacts of introducing Vaccae vaccination in China
INTRODUCTION: Given the ageing epidemic of tuberculosis (TB), China is facing an unprecedented opportunity provided by the first clinically approved next-generation TB vaccine Vaccae, which demonstrated 54.7% efficacy for preventing reactivation from latent infection in a phase III trial. We aim to assess the population-level health and economic impacts of introducing Vaccae vaccination to inform policy-makers. METHODS: We evaluated a potential n…
Translating and disseminating a localised economic model to support implementation of the ‘Ending the HIV Epidemic’ initiative to public health policymakers
To optimise acceptance and use of results from economic models, researchers should engage with local community members and public health decision makers early to understand budgetary and community priorities. Participants prioritised evidence that supports their existing strategies, considers budgets and funding streams, and improves health equity; however, real-world budget constraints and conflicting interests serve as barriers to implementing …
Incorporating productivity loss in health economic evaluations
INTRODUCTION: Productivity loss may contribute to a large proportion of costs of health conditions in an economic evaluation from a societal perspective, but there is currently a lack of methodological consensus on how productivity loss should be measured and valued. Despite the research progress surrounding this issue in other countries, it has been rarely discussed in China. METHODS: We reviewed the official guidelines on economic evaluations i…
The estimated costs and benefits of a hypothetical supervised consumption site in Providence, Rhode Island
Targeting community-based naloxone distribution using opioid overdose death rates
Addressing methodological and ethical issues in practicing health economic evaluation in China
ealth economic evaluations provide guidance for allocating resources and improving health outcomes. In low-and middle-income countries with limited health resources such as China, economic evaluation should have a more significant role than it does. However, several practical issues may hamper the development of economic evaluations in China, including cost inventory, measurement of health outcomes, thresholds for willingness-to-pay, validity and…
Enumeration 2024
Objectives. To expand on previous enumerations by assessing the size and composition of the governmental public health workforce in the wake of the COVID-19 pandemic, identifying workforce trends, occupational distributions, and potential gaps in staffing. Methods. From 2023 to 2024, using 2022 data in the United States, we conducted 3 distinct analyses: (1) estimating the total workforce size, (2) profiling occupation-specific distributions, and…
Addressing methodological and ethical issues in practicing health economic evaluation in China
ealth economic evaluations provide guidance for allocating resources and improving health outcomes. In low-and middle-income countries with limited health resources such as China, economic evaluation should have a more significant role than it does. However, several practical issues may hamper the development of economic evaluations in China, including cost inventory, measurement of health outcomes, thresholds for willingness-to-pay, validity and…
Targeting community-based naloxone distribution using opioid overdose death rates
Incorporating productivity loss in health economic evaluations
INTRODUCTION: Productivity loss may contribute to a large proportion of costs of health conditions in an economic evaluation from a societal perspective, but there is currently a lack of methodological consensus on how productivity loss should be measured and valued. Despite the research progress surrounding this issue in other countries, it has been rarely discussed in China. METHODS: We reviewed the official guidelines on economic evaluations i…
The estimated costs and benefits of a hypothetical supervised consumption site in Providence, Rhode Island
Population-level health and economic impacts of introducing Vaccae vaccination in China
INTRODUCTION: Given the ageing epidemic of tuberculosis (TB), China is facing an unprecedented opportunity provided by the first clinically approved next-generation TB vaccine Vaccae, which demonstrated 54.7% efficacy for preventing reactivation from latent infection in a phase III trial. We aim to assess the population-level health and economic impacts of introducing Vaccae vaccination to inform policy-makers. METHODS: We evaluated a potential n…
Translating and disseminating a localised economic model to support implementation of the ‘Ending the HIV Epidemic’ initiative to public health policymakers
To optimise acceptance and use of results from economic models, researchers should engage with local community members and public health decision makers early to understand budgetary and community priorities. Participants prioritised evidence that supports their existing strategies, considers budgets and funding streams, and improves health equity; however, real-world budget constraints and conflicting interests serve as barriers to implementing …
Enumeration 2024
Objectives. To expand on previous enumerations by assessing the size and composition of the governmental public health workforce in the wake of the COVID-19 pandemic, identifying workforce trends, occupational distributions, and potential gaps in staffing. Methods. From 2023 to 2024, using 2022 data in the United States, we conducted 3 distinct analyses: (1) estimating the total workforce size, (2) profiling occupation-specific distributions, and…
Enumerating the State and Local Public Health Workforce During the Covid-19 Response
Objectives. To understand the landscape of the nonfederal governmental public health workforce and to identify replicable methods for future enumerations. Methods. This enumeration of the state and local public health workforce was conducted from 2023 to 2024 and triangulated the National Association of County and City Health Officials (NACCHO) Profile 2022 and the Association of State and Territorial Health Officials (ASTHO) Profile 2022. We uti…
A descriptive study of drug overdose epidemics, overdose prevention efforts, and opioid settlement fund distribution across six states
Medicine (7 works) · Environmental health (5 works) · Nursing (5 works) · Political science (5 works) · Public health (5 works) · Business (4 works) · Health Policy (3 works) · HIV, Drug Use, Sexual Risk (3 works) · Opioid Use Disorder Treatment (3 works) · Population (3 works)